about
sameAs
Gold(I)-triphenylphosphine complexes with hypoxanthine-derived ligands: in vitro evaluations of anticancer and anti-inflammatory activitiesGold(I) complexes of 9-deazahypoxanthine as selective antitumor and anti-inflammatory agentsZn(II)-Chlorido complexes of phytohormone kinetin and its derivatives modulate expression of inflammatory mediators in THP-1 cells.Effect of 2-chloro-substitution of adenine moiety in mixed-ligand gold(I) triphenylphosphine complexes on anti-inflammatory activity: the discrepancy between the in vivo and in vitro models.Pharmacological and molecular effects of platinum(II) complexes involving 7-azaindole derivatives.TNF-α signalling and inflammation: interactions between old acquaintances.The Structure-Antimicrobial Activity Relationships of a Promising Class of the Compounds Containing the N-Arylpiperazine Scaffold.The Chemical Composition of Achillea wilhelmsii C. Koch and Its Desirable Effects on Hyperglycemia, Inflammatory Mediators and Hypercholesterolemia as Risk Factors for Cardiometabolic Disease.Turkish Scorzonera Species Extracts Attenuate Cytokine Secretion via Inhibition of NF-κB Activation, Showing Anti-Inflammatory Effect in Vitro.Diverse in vitro and in vivo anti-inflammatory effects of trichlorido-gold(III) complexes with N6-benzyladenine derivatives.Prenylated and geranylated flavonoids increase production of reactive oxygen species in mouse macrophages but inhibit the inflammatory response.Investigation of sanguinarine and chelerythrine effects on LPS-induced inflammatory gene expression in THP-1 cell line.Cytotoxicity and effects on inflammatory response of modified types of cellulose in macrophage-like THP-1 cells.Natural compound cudraflavone B shows promising anti-inflammatory properties in vitro.Hepatoprotective and TNF-α inhibitory activity of Zosima absinthifolia extracts and coumarins.C-Geranylated Flavanones from Paulownia tomentosa Fruits as Potential Anti-inflammatory Compounds Acting via Inhibition of TNF-α Production.Prenylated Flavonoids from Morus alba L. Cause Inhibition of G1/S Transition in THP-1 Human Leukemia Cells and Prevent the Lipopolysaccharide-Induced Inflammatory Response.Cellular responses induced by Cu(II) quinolinonato complexes in human tumor and hepatic cells.Flavonoid 4'-O-Methylkuwanon E from Morus alba Induces the Differentiation of THP-1 Human Leukemia CellsAntiradical and cytoprotective activities of several C-geranyl-substituted flavanones from Paulownia tomentosa fruit.Effect of solvent on cytotoxicity and bioavailability of fatty acids.Artichoke Leaf Extract Inhibits AKR1B1 and Reduces NF-κB Activity in Human Leukemic Cells.Dinuclear metal(ii)-acetato complexes based on bicompartmental 4-chlorophenolate: syntheses, structures, magnetic properties, DNA interactions and phosphodiester hydrolysis.Diplacone and mimulone ameliorate dextran sulfate sodium-induced colitis in rats.Anti-inflammatory Activity of Natural Geranylated Flavonoids: Cyclooxygenase and Lipoxygenase Inhibitory Properties and Proteomic Analysis.Metabolite profiling of "green" extracts of Corylus avellana leaves by H NMR spectroscopy and multivariate statistical analysisAnti-Infectivity against Herpes Simplex Virus and Selected Microbes and Anti-Inflammatory Activities of Compounds Isolated from LabillEvaluation of anti-inflammatory activity of prenylated substances isolated from Morus alba and Morus nigraArtichoke leaf extract, as AKR1B1 inhibitor, decreases sorbitol level in the rat eye lenses under high glucose conditions ex vivoLC-MSn and HR-MS characterization of secondary metabolites from Hypericum japonicum Thunb. ex Murray from Nepalese Himalayan region and assessment of cytotoxic effect and inhibition of NF-κB and AP-1 transcription factors in vitroInvestigation of Anti-Inflammatory Potential of N-Arylcinnamamide Derivatives
P50
Q28543014-329E4FA6-F344-4C4A-A9E7-595D62517C2CQ28543791-69CFF797-2155-4BC2-A872-2338C326C931Q34766209-DF2227AC-B0C7-4597-A568-70740F275EB0Q35060920-5FE823A3-58B5-42B4-9DB1-9FAE712C6450Q35112827-401652F0-5D51-4076-9469-4E2EE2327AF8Q38107792-E34FCA77-5D7B-49C4-8143-B18D5274C3CEQ38743289-FB284F13-94BD-4765-A019-956AB2547D79Q38782616-2D06D283-6CAD-4051-A657-AB291A89B995Q38806695-A33F517E-523C-430D-88EA-3DA1F5614079Q39019481-6D9351EE-12F0-4117-8520-BC150B60C345Q39110066-98EFBD57-BB35-466F-93EC-D87EC1CC8A07Q39347318-7F3F0800-E5D6-4F74-A1E1-528C1EF2563FQ39585438-B85DE930-2D3F-4F9C-B3CD-F552676CAD6FQ39592612-BFF05F60-C7F9-4EDB-B7F7-4BE2BD70433EQ39615619-BF46FFE0-25CE-4A98-83FD-F2DCC2F59880Q41309486-51695958-E599-4EC4-8F48-DDDB13750673Q41479196-884A2188-1DCC-4EDC-A758-A0ABEAB90D5AQ41775376-DD1EABB2-9828-4F8A-BF90-4A6A7BF993CBQ42096403-5E93F092-0D56-404A-BF17-F4C97278182EQ42874545-07ED9367-4244-476D-9525-337EC9380564Q43185915-54A525E0-EEDC-4658-9242-0723A876A023Q46426990-9E31B33C-8630-4946-932A-EE7E2F919132Q46507871-0CAB44C4-675C-44AB-A398-5CBA7B8930B4Q46782003-06FD6723-F24B-4680-AA2F-262D4F661C3DQ48098400-9FC54754-0397-4E9C-B080-06BDE40E64D7Q57787829-6538E3B9-8F0E-4FE0-B359-91A6BBAC20A2Q59357402-398F5C93-F0AE-4114-ADD4-42F6043F8FBCQ88025373-DA8600C3-AFEB-4953-9037-E0513D95055DQ90955037-E543C615-5B72-45D5-9820-0357BF6B9172Q91745342-9D9A4292-5597-4BF2-B438-9366F8E947E1Q91965142-5742A5B0-35D3-454C-96E6-3ABF32C953AF
P50
description
Narozen 19. 2. 1983. RNDr., Ph ...... iky a molekulární diagnostiky.
@cs
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jan Hošek
@ast
Jan Hošek
@cs
Jan Hošek
@de
Jan Hošek
@en
Jan Hošek
@es
Jan Hošek
@nl
Jan Hošek
@sk
Jan Hošek
@sl
type
label
Jan Hošek
@ast
Jan Hošek
@cs
Jan Hošek
@de
Jan Hošek
@en
Jan Hošek
@es
Jan Hošek
@nl
Jan Hošek
@sk
Jan Hošek
@sl
prefLabel
Jan Hošek
@ast
Jan Hošek
@cs
Jan Hošek
@de
Jan Hošek
@en
Jan Hošek
@es
Jan Hošek
@nl
Jan Hošek
@sk
Jan Hošek
@sl
P214
P1053
B-6274-2009
P1153
24484447300
P21
P214
P31
P3829
P496
0000-0003-0975-1671
P569
1983-02-19T00:00:00Z